SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as anticipation builds for the HOPE-3 trial data release, with discussions focusing on potential outcomes and their impact on the stock. Longs express optimism, fueled by positive signals and analyst ratings, while shorts highlight risks and past trial results, leading to a battle of conviction within the community. Some traders speculate about a potential data leak or a strategic short squeeze, intensifying the focus on the imminent announcement.

Fly-E Group, Inc. is an electric vehicle company, which engages in designing, installing, and selling smart electric motorcycles, electric bikes, electric scooters, and related accessories under the brand Fly E-Bike. Its products include electric-scooter, e-bikes, parts, and accessories. The company was founded by Zhou Ou in 2018 and is headquartered in Flushing, NY.

Fly-E Group Inc.

Fly-E Group Inc

FLYE is experiencing significant volatility, driven by discussions around its high short interest and potential for a short squeeze. The community is actively debating entry and exit strategies, with some eyeing quick profits while others consider overnight holds. Recent price jumps from previous lows have intensified speculation, though some caution against the lack of news and potential for rapid declines.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending downwards, with community members expressing concerns about its correlation to Bitcoin's volatility and the company's financial strategy. Discussions revolve around whether the stock is undervalued or a potential value trap, with some traders betting against the stock as they question the sustainability of the company's current approach. The broader conversation includes scrutiny of management decisions and their impact on shareholder value.

In a world buzzing with activity, where drones are built for work, speed, and precision, one drone dared to be different. Meet Chill Drone – the laid-back, cloud-surfing anomaly that embodies the essence of relaxation. Born from the scrap pile of a high-tech lab, Chill Drone was a prototype that never quite fit the mold. Instead of hyper-efficiency and tireless productivity, Chill Drone discovered its true purpose: taking it slow, enjoying the ride, and reminding us all to chill out.  While other drones tirelessly plotted world domination, designing grand schemes to conquer humanity or control resources, Chill Drone wanted none of it. Why dominate the world when you can lay back on a fluffy cloud and watch the sunset? Chill Drone’s motto became clear: “World domination is overrated; tranquility is the true power.”  Chill Drone’s refusal to conform made it an outcast among its kind, but it also made it a hero to those yearning for a break from the relentless grind. With its half-open eyes, relaxed propellers, and signature serene vibe, Chill Drone soared above the chaos, proving that being different is not just okay – it’s awesome.

Chill Drone

Chill Drone ($CHONE) is trending downwards amidst concerns about vanishing risk appetite and drying liquidity. The crypto faces heavy selling pressure, a failed breakout, and a firmly intact downtrend. The community is highlighting bearish reversal signals and increasing negative momentum.

Coincheck Group NV operates multi-cryptocurrency marketplaces and crypto asset exchanges in Japan. It provides exchange platforms on cryptocurrencies including Bitcoin and Ethereum. It owns the Next Finance Tech Company Limited that offers staking services to retail customers and corporate clients. The company was founded on February 18, 2022 and is headquartered in Amsterdam, Netherland.

Coincheck Group N.V.

Coincheck Group ($CNCK) is trending following Q3 '25 earnings, which revealed substantial year-over-year revenue and net income growth. Community members are discussing the potential for increased PR and news to improve liquidity, as well as the implications of Monex's share unlock in December. Some traders are noting its potential as a sleeper play in the crypto exchange market, drawing comparisons to Coinbase.

Ambitions Enterprise Management Co LLC

AHMA is trending due to its low float and recent IPO status, leading to discussions about potential for significant price movement. Community members are pointing to similarities with other recent low float runners and anticipating further gains. The stock's volatile price action, including halts, is also a key talking point among traders.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices reach new highs, driven by industrial demand from AI and EVs, coupled with supply constraints. Community discussions revolve around whether this rally signals a genuine squeeze and the debate between physical versus paper silver. Many traders are also suggesting that silver could outperform gold as a better hedge against crypto volatility.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

ALAB is trending as investors discuss its potential in the AI infrastructure space and recent price action, including a significant pullback and potential breakout patterns. Community members are weighing the impact of competitor announcements and partnerships, as well as considering technical indicators and potential entry points ahead of upcoming earnings. The community's sentiment is mixed, with some seeing a buying opportunity and others expressing concern about valuation and market share.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending as investors anticipate earnings and assess its position in the AI landscape. Community discussions revolve around potential ER outcomes and the stock's historical volatility around reporting. Recent news of expanded cloud security collaboration with Microsoft in Europe is also contributing to the buzz.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is trending as investors react to the company's recent emergence from Chapter 11 bankruptcy and restructuring, with community members speculating on the potential for a short squeeze given the reduced debt and new equity structure. Bullish sentiment is fueled by the company's position in silicon carbide technology and potential government support, while others remain cautious due to past losses and potential dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Citius Oncology (CTOR) said on Monday it has launched&nbsp;Lymphir, a newly approved cancer immunotherapy for adults with relapsed or refractory Stage I–III cutaneous T-cell lymphoma (CTCL), making the drug available nationwide through specialty distributors.The U.S. Food and Drug Administration (FDA) approved Lymphir, also known as denileukin diftitox-cxdlfor adults with cutaneous T-cell lymphoma, a form of skin cancer that can cause painful, itchy lesions. The drug is an IL-2 receptor-directed fusion protein designed to kill IL-2R–expressing cancer cells while depleting regulatory T cells.The stock jumped nearly 14% at the time of writing.&nbsp;Get updates to this developing story directly on Stocktwits.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Citius Oncology stock (CTOR) jumped nearly 14% at the time of writing.  (Photo credit: Getty Images)

Citius Oncology Launches Lymphir In US For Skin Cancer

The drug is an IL-2 receptor-directed fusion protein designed to kill IL-2R–expressing cancer cells while depleting regulatory T cells.

Equity

Frame 485.png

Get the daily email that keeps you tuned in and makes markets fun again.

Frame 484.png

The most relevant Indian markets intel delivered to you everyday.

cryptotwits - 800x800.png

Get the daily crypto email you’ll actually love to read. It's value-packed, data-driven, and seasoned with wit.

Frame 479.png

The best trade ideas and analysis from the Stocktwits community. Delivered daily by 8 pm ET.

Frame 486.png

For serious investors with a serious sense of humor.

Frame 487.png

High Relative Strength, Low Social Following

Citius Oncology Launches Lymphir In US For Skin Cancer

Latest News